John’s Substack
Decision JunctionMy personal Substack
| Platform |  | Pricing | Freemium | Publishes | Twice weekly |
|---|---|---|---|---|---|
| Issues | 70 | Founded | 2 years ago | Last Issue | 7 days ago |
| Active | |||||
Read this Newsletter
johncatanzaro.substack.comLatest Issues
The New Standard of Care Has Already Begun
For decades, the dominant model of care has remained fundamentally reactive:
wait for symptoms, identify pathology, intervene after dysfunction has already progressed.
The problem is that biology does not suddenly fail overnight.
John’s...
The Genetic Gamble
Author: John A. Catanzaro; CEO Neo7Bioscience
In collaboration with Dr. Peter A. McCullough, Nicolas Hulscher, and the McCullough Foundation
Serious Biological Warning
The next generation of medicine is being sold as “precision hea...
Beyond Symptom Management: The Molecular Restoration of Post-mRNA Vaccine Injury
For years, medicine has operated under a familiar framework:
Identify symptoms.
Assign a diagnosis.
Suppress the condition.
Manage progression.
But what happens when patients fall outside the framework itself?
John’s Substack is a...
The Genetic Dangers of Vaccination Against Hantavirus
John A. Catanzaro, CEO of Neo7Bioscience
In Collaboration With Dr. Peter A. McCullough, Nicolas Hulscher, and The McCullough Foundation
Subscribe
A Transcriptional and Epigenetic Perspective
The emergence of advanced genetic vacci...
The Era of Molecular Surveillance
Modern medicine was built on a delayed model of care.
A patient feels symptoms.
A test is ordered.
A diagnosis is assigned.
Treatment begins after dysfunction has already established itself inside the body.
For decades, this framewo...
Audience Metrics
Subscribers, engagement, traffic and sponsorship for John’s Substack.
| Subscribers | Engagement | 78 | Monthly Web Visits | ||
|---|---|---|---|---|---|
| Accepts Sponsors | Estimated Cost per Ad | ||||
Explore More
Authors
The writers behind this newsletter.
Dr. John Catanzaro, Co-founder of Neo7Bioscience, merges human intelligence with PBIMA (aHI) technology in molecular bioscience. His 30+ years of experience in molecular technology and personalized peptide engineering, shines on Decision Junction.
Frequently Asked Questions
How can I access the email archive for John’s Substack?
You can find recent issues that have been published by John’s Substack on Reletter by scrolling up to where it says Latest Issues. Tap on the link for any of the most recent emails or hit More Issues to see older ones.
How many subscribers does John’s Substack have?
To see how many people subscribe to John’s Substack, simply upgrade your Reletter account. We provide readership numbers and lots of other stats for this newsletter so you can decide if it's worth reaching out to.
How can I advertise in John’s Substack?
Newsletter advertising can be extremely effective when it's done right. Before you pitch John’s Substack as a potential sponsor or partner, make sure that you've done your research and checked its newsletter stats with Reletter.
Then, personalize one of our winning pitching templates and send it to the right person using the contact info provided.
How much does it cost to sponsor a publication like John’s Substack?
Newsletter ad rates (or CPM) vary depending on many factors, including industry, number of subscribers, open rate, ad placement and more.
To find out how much an ad will cost, contact John’s Substack using the contact information provided and ask for a copy of their media kit.
How can I find newsletters related to John’s Substack?
Scroll up to where it says Related Newsletters to see other publications like John’s Substack. You can also search our email newsletter directory to discover other newsletters that cover the topics you're interested in.
How do I contact John’s Substack?
Reletter provides this newsletter's website URL above, where you will often find their contact information. We also provide links to associated social media accounts and pitching templates so you can reach out fast.